WHO ICTRP trial

Vitreorretinal surgery with and without oral anticoagulants: results and…

EUCTR2018-000753-45-ES · EU Clinical Trials Register · Authorised

Key facts

Trial ID EUCTR2018-000753-45-ES
Public title Vitreorretinal surgery with and without oral anticoagulants: results and complications.
Scientific title Vitreretinal surgery with and without oral anticoagulants: surgical complications, visual results and perioperative thromboembolic events.
Primary sponsor NAVARRBIOMED-FUNDACION MIGUEL SERVET
Registry EU Clinical Trials Register
Recruitment status Authorised
Study type Interventional clinical trial of medicinal product
Phase Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): yes
Countries Spain
Conditions Patients undergoing vitreoretinal surgery under treatment with oral anticoagulants;Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Surgical Procedures, Operative [E04]
Interventions Trade Name: PRADAXA Product Name: Dabigatran Pharmaceutical Form: Capsule, hard INN or Proposed INN: DABIGATRAN CAS Number: 872728-81-9 Other descriptive name: DABIGATRAN ETEXILATE MESILATE Concentration unit: mg milligram(s) Concentration…
Registration date Jun 20, 2018
Target size 96
Secondary IDs NAVIT-18
Registry page clinicaltrialsregister.eu

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations